October 13, 2015

Marin Cilic’s Doping Ban Reduced; Can Go Back on Tour Next Week


(October 25, 2013)  Marin Cilic’s doping ban has been reduced from nine months to four. This will allow Cilic to return to the tour next week to play the Paris Masters if he chooses to.


The 25-year-old Croatian whose ranking once peaked at No. 9 in the world, tested positive for nikethamide in May at an event in Munich. Cilic challenged the ban citing that he did not mean to take the substance found in glucose tablets. He accepted a ban in June. His ranking has fallen to No. 47 in the world.


The International Tennis Federation released the following press release:


The International Tennis Federation announced that the Court of Arbitration for Sport (“CAS”) has partially upheld the appeal by Marin Cilic against the decision of the independent tribunal dated 23 September 2013. The independent tribunal had determined that Mr Cilic should be suspended from participation for a period of 9 months, commencing from 1 May 2013 (the date on which the sample containing the prohibited substance was collected) and so ending at midnight on 31 January 2014 for the commission of an Anti-Doping Rule Violation under Article C.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s sample).
The CAS panel decided that the independent tribunal’s decision be set aside, and replaced with a period of ineligibility of four months, with the start back-dated to 26 June 2013, the date on which Mr Cilic accepted a voluntary provisional suspension. He thus will be eligible to participate on 26 October 2013.


Mr Cilic’s results from the BMW Open remain disqualified, including forfeiture of the prize money and ranking points won at that event. Mr Cilic’s results subsequent to the BMW Open will not be disqualified and he is permitted to retain the ranking points and prize money that he won at those events.


The full decision, with reasons, will follow in due course.


The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.